摘要
目的:观察芪风颗粒及依巴斯汀对慢性荨麻疹的临床治疗效果。方法:采用对照实验研究方法将我院门诊患者随机分成观察组和对照组。观察组(n=50)应用芪风颗粒和依巴斯汀联合治疗,对照组(n=50)应用盐酸西替利嗪和防风通圣丸联合治疗。两组均以21 d为1个疗程,于治疗结束后2周观察临床疗效。结果:两组总有效率分别为98%和78%,两组之间比较差异有统计学意义(P<0.01)。结论:芪风颗粒及依巴斯汀联合应用对慢性荨麻疹有明显疗效,并且能显著降低慢性荨麻疹的复发几率,可作为治疗慢性荨麻疹的有效方法。
Objective：To observe the clinical therapeutic effect of qifeng particles and ebastine in treatment of chronic urticaria. Methods：Outpatients with chronic urticaria were randomly divided into observation group（ n = 50） and control group（ n = 50）. The observation group received qifeng particles and ebastine, and control group with certirizine hydrochloride and fangfengtongsheng pill. The therapeutic effect in both groups were evaluated after therapy for 21 days. Results： The total effective rate was separatively 98% and 78%, showing significant differance（P 〈 0.01）. Conclusion： Qifeng particles and ebastine is effective in treatment of chronic urticaria. The medicines could reduce the recurrence of chronic urticaria.
出处
《内蒙古医学杂志》
2009年第5期549-550,共2页
Inner Mongolia Medical Journal
